The Czech Republic Analgesic Industry Outlook 2022 - 2026

See how the Czech Republic Analgesic performed compared to key markets such as Germany, Spain and Canada.

Key Market Indicators

Sales of Czech analgesic medicines are projected to reach $131.6 million by 2026, up from $123 million in 2021. This represents a yearly growth rate of about 1.4%. Since 1995, the Czech market has seen an average growth of 6% each year. In 2021, the country ranked 13th in terms of sales, behind Denmark's $123 million. Spain, Canada and Italy completed the top four list, coming in second, third and fourth respectively.

Marketing Banner

The Czech Republic Analgesic Market Data and Forecasts

How much will the Czech Republic Analgesic Market grow to 2026?

Forecast: Analgesic Medicine Sales in the Czech Republic
More in Analgesic Industry for 2028